Curaleaf Holdings (CURLF) Liabilities from Discontinued Operations (2020 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Liabilities from Discontinued Operations of 7073000.0 for Q4 2025, down 20.57% year-over-year from 8905000.0 in Q4 2024, and down 20.57% quarter-over-quarter from 8905000.0 in Q4 2024.
Curaleaf Holdings (CURLF) Liabilities from Discontinued Operations (2020 - 2026) Analysis & Trends
Curaleaf Holdings' Liabilities from Discontinued Operations history runs 6 years deep, the most recent figure standing at 7073000.0 for Q4 2025.
- In Q4 2025, Liabilities from Discontinued Operations fell 20.57% year-over-year to 7073000.0; the TTM figure through Dec 2025 stood at 7073000.0 (down 20.57% YoY), while the FY2025 annual figure was 7073000.0, down 20.57% from the prior year.
- Liabilities from Discontinued Operations for Q4 2025 stood at 7073000.0, down from 8905000.0 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was 23045000000.0 in Q1 2022, with the low at 1067000.0 in Q3 2024.
- The 5-year median for Liabilities from Discontinued Operations is 12775000.0 (2021), against an average of 1549350066.67.
- The sharpest annual moves came in 2022 and 2024: Liabilities from Discontinued Operations surged 180291.39% in 2022, then plunged 95.67% in 2024.
- Curaleaf Holdings' Liabilities from Discontinued Operations stood at 18581000.0 in 2021, then surged by 91.3% to 35545000.0 in 2022, then sank by 74.19% to 9173000.0 in 2023, then fell by 2.92% to 8905000.0 in 2024, then decreased by 20.57% to 7073000.0 in 2025.
- Business Quant data shows CURLF's Liabilities from Discontinued Operations at 7073000.0 in Q4 2025, 8905000.0 in Q4 2024, and 1067000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Curaleaf Holdings | 2.49 Bn | 2.39 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.79 Mn |
| Jun 30, 2026 | 6.79 Mn |
| Dec 31, 2025 | 7.07 Mn |
| Dec 31, 2025 | 7.07 Mn |
| Dec 31, 2024 | 8.91 Mn |
| Dec 31, 2024 | 8.91 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Dec 31, 2023 | 9.17 Mn |
| Dec 31, 2023 | 9.17 Mn |
| Sep 30, 2023 | 24.62 Mn |
| Sep 30, 2023 | 24.62 Mn |
| Jun 30, 2023 | 10.51 Mn |
| Jun 30, 2023 | 10.51 Mn |
| Dec 31, 2022 | 35.55 Mn |
| Dec 31, 2022 | 35.55 Mn |
| Sep 30, 2022 | 15.83 Mn |
| Sep 30, 2022 | 15.83 Mn |